● Recruiting

To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy

Condition: Transthyretin Amyloid Polyneuropathy · Sponsor: Qilu Pharmaceutical Co., Ltd.

PhasePhase 4

Planned participants15

Who can joinAll sexes, 18 Years to 80 Years

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the efficacy and safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients with Transthyretin Amyloid Polyneuropathy

This description comes directly from the study's public registry record.

Talk to the study team

chuanzhu yan, Doctor · 18560082288 · zzl2002@medmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Qilu Hospital of Shandong University

Jinan, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06940336